Brief: PCI Biotech Says Independent Data Monitoring Committee Recommends Continuation Of Two Treatments In Release Trial
Dec 13 (Reuters) - PCI Biotech Holding ASA PCIB.OL :
* INDEPENDENT DATA MONITORING COMMITTEE RECOMMENDS
CONTINUATION OF
TWO TREATMENTS IN RELEASE TRIAL
Source text for Eikon: ID:nGNE4HLJ2m
Further company coverage: PCIB.OL
((Reuters.Briefs@thomsonreuters.com;))
Recent news on PCI Biotech Holding ASA
See all newsBrief: Euronext Oslo Børs To Delist PCI Biotech Holding Shares
Brief: Euronext Oslo Børs Gets Application From PCI Biotech Holding For Delisting
Brief: PCI Biotech Holding Board Proposes Dissolution, Delisting
Brief: Oslo Bors: PCI Biotech Holding Is Placed In Recovery Box
Brief: PCI Biotech Says Co Initiates Process To Evaluate Opportunity For Structured Wind-Up Process